Clinical trial
Study of the Importance of Intestinal Microbiota in Patients With Heart Failure - Randomized, Double-blind Study
NCT03968549 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Importance of Intestinal Microbiota in Patients With Heart Failure - Randomized, Double-blind Study
- Lead sponsor
- University of Sao Paulo General Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 6, 2018
- Completion date
- August 31, 2020
- Enrollment
- 58 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.